Outcomes associated with non-recommended dosing of rivaroxaban: results from the XANTUS study. eur heart j cardiovasc pharmacother • April 23, 2019
Safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism – a nationwide study. eur heart j cardiovasc pharmacother • June 27, 2018